Celularity CELU
NASDAQ CELU
$1.43 -0.01 (-0.69%)
As of: Sep 10, 2026 · 2:25 PM EDT

Celularity (CELU) Tax Provisions (2019 - 2024)

Celularity's (CELU) quarterly Tax Provisions came in at -$12.2 million in Q4 2024, down 121660.0% year-over-year from N/an in Q1 2024, and down 121660.0% quarter-over-quarter from $10000.0 in Q4 2023.

Analysis

Celularity (CELU) Tax Provisions (2019 - 2024) Analysis & Trends

Celularity (CELU) has reported Tax Provisions for 6 consecutive years, with -$12.2 million the latest figure, recorded in Q4 2024.

  • On a quarterly basis, Tax Provisions fell 121660.0% year-over-year to -$12.2 million in Q4 2024; TTM through Dec 2024 was -$12.2 million, a 121660.0% decrease from a year earlier, with the FY2025 full-year figure at -$19.3 million, down 58.51% from the prior year.
  • Tax Provisions was -$12.2 million for Q4 2024 at Celularity, down from $10000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $272639.0 in Q1 2020 and troughed at -$12.2 million in Q4 2024.
  • A 5-year average of -$994377.6 and a median of $11500.0 in 2022 frame the typical range for Tax Provisions.
  • Across the five-year window, Tax Provisions soared 214.49% in 2021 and sank 121660.0% in 2024, its largest moves.
  • Over 5 years, Tax Provisions stood at -$69000.0 in 2020, then jumped by 128.99% to $20000.0 in 2021, then plunged by 35.0% to $13000.0 in 2022, then declined by 23.08% to $10000.0 in 2023, then slumped by 121660.0% to -$12.2 million in 2024.
  • The last three Tax Provisions figures came in at -$12.2 million (Q4 2024), $10000.0 (Q4 2023), and $13000.0 (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Krystal Biotech 10.22 Bn 9.38 Bn 112.79 Mn 11.31 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 1.00 Mn
3 Iovance Biotherapeutics 3.64 Bn 3.34 Bn 55.72 Mn -1.40 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn -22.30 Mn
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn 1.84 Mn
6 Beam Therapeutics 2.52 Bn 2.52 Bn - -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.15 Bn 1.35 Bn 251.87 Mn 3.14 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 Celularity 36.61 Mn 30.43 Mn -3.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -12.16 Mn
Dec 31, 2023 10,000.00
Dec 31, 2022 13,000.00
Sep 30, 2022 -17,000.00
Jun 30, 2022 17,000.00
Dec 31, 2021 20,000.00
Jun 30, 2021 43,700.00
Mar 31, 2021 -43,700.00
Dec 31, 2020 -69,000.00
Sep 30, 2020 15,000.00
Jun 30, 2020 -38,170.00
Mar 31, 2020 272,639.00
Dec 31, 2019 201,523.00
Sep 30, 2019 298,032.00
Jun 30, 2019 168,675.00